| Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate Cancer (NCT03098836) | Daniel George, MD | 2017-07-10 |
| B-lines Lung Ultrasound Guided ED Management of Acute Heart Failure Pilot Trial (NCT03136198) | Indiana University | 2017-07-10 |
| Proton Re-Irradiation for Recurrent Head and Neck Cancer (NCT03217188) | Memorial Sloan Kettering Cancer Center | 2017-07-10 |
| Pasireotide LAR Therapy of Silent Corticotroph Pituitary Tumors (NCT02749227) | Columbia University | 2017-07-10 |
| Study of AZD6094 (Volitinib) in Combination With Docetaxel, in Advanced Gastric Adenocarcinoma Patients With MET Overexpression as a Second-line Treatment (NCT02447380) | Samsung Medical Center | 2017-07-10 |
| CD19 CAR-T Consolidation Therapy for Acute Lymphoblastic Leukemia (NCT03984968) | The First Affiliated Hospital of Soochow University | 2017-07-10 |
| Adjuvant Nivolumab Following Chemo-Radiation in Localized Muscle-Invasive Bladder Cancer (NCT03171025) | University of Utah | 2017-07-10 |
| Effects of EPA in Men With Biochemical Recurrence or Progression of Prostate Cancer. (NCT03753334) | CHU de Quebec-Universite Laval | 2017-07-10 |
| A Study of the Efficacy and Safety of Alectinib in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NCT03155009) | Hoffmann-La Roche | 2017-07-10 |
| The Effect of Topical Brimonidine Tartrate on Hand-foot Syndrome (HFS) in Cancer Patients (NCT03173365) | Heinrich-Heine University, Duesseldorf | 2017-07-10 |
| Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia (NCT02826681) | American Regent, Inc. | 2017-07-10 |
| Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer (NCT03579004) | Mona Frolova | 2017-07-10 |
| Multiple Treatment Session Study to Assess GSK2398852 Administered Following and Along With GSK2315698 (NCT03044353) | GlaxoSmithKline | 2017-07-10 |
| Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma (NCT02969837) | University of Chicago | 2017-07-10 |
| CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab (NCT03123783) | Apexigen America, Inc. | 2017-07-10 |
| A Comparative Effectiveness Randomised Placebo Controlled Pilot Trial of the Management of Acute Lumbar Radicular Pain (NCT03240783) | St George Hospital, Australia | 2017-07-08 |
| Early Phase 2 Clinical Study of TS-142 in Patients with Insomnia Disorder (NCT04573725) | Taisho Pharmaceutical Co., Ltd. | 2017-07-07 |
| DLAAG in the Treatment of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome With Blast Excess (NCT03356080) | Shanghai Tong Ren Hospital | 2017-07-07 |
| Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer (NCT02873195) | Academic and Community Cancer Research United | 2017-07-07 |
| Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia (NCT03087058) | Vifor Pharma, Inc. | 2017-07-07 |
| Ph II Nintedanib vs. Ifosfamide in Soft Tissue Sarcoma (NCT02808247) | European Organisation for Research and Treatment of Cancer - EORTC | 2017-07-07 |
| Geriatric Assessment & Genetic Profiling to Personalize Therapy in Older Adults With Acute Myeloid Leukemia (NCT03226418) | University of Nebraska | 2017-07-07 |
| Trial Using Octreotide to Enhance Liver Recovery After Hepatectomy (NCT03179995) | Fox Chase Cancer Center | 2017-07-07 |
| Nivolumab in Recurrent and/or Metastatic SCCHN (NCT03226756) | UNICANCER | 2017-07-07 |
| A Phase 2 Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Varnish and Strip in Adolescent and Adult Subjects (NCT03196219) | Armata Pharmaceuticals, Inc. | 2017-07-07 |
| Ziv-aflibercept Efficacy in Better Regulating AMD (NCT03423823) | Kapil Kapoor | 2017-07-07 |
| Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma (NCT03041701) | National Cancer Institute (NCI) | 2017-07-07 |
| Trial of Idelalisib in Patients With Relapsed Diffuse Large B-cell Lymphoma (NCT03576443) | Nordic Lymphoma Group | 2017-07-07 |
| Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer (NCT02860000) | Mayo Clinic | 2017-07-06 |
| Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy (NCT03039686) | Hoffmann-La Roche | 2017-07-06 |
| Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty (NCT03169231) | Longeveron Inc. | 2017-07-06 |
| Fulvestrant Plus Enzalutamide in ER+/Her2- Advanced Breast Cancer (NCT02953860) | University of Colorado, Denver | 2017-07-06 |
| Extension Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD) (NCT03167255) | NS Pharma, Inc. | 2017-07-06 |
| Prostate Cancer Survivors and Exercise and Behavioral Counseling (NCT03191968) | University of Illinois at Urbana-Champaign | 2017-07-06 |
| TWB-103 for Adult Patients With Split-Thickness Skin Graft Donor Site Wounds (NCT02737748) | Transwell Biotech Co., Ltd. | 2017-07-06 |
| Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Transitional Cell Carcinoma (NCT03219775) | AIO-Studien-gGmbH | 2017-07-06 |
| RTMS for Treatment of Pain and Craving (NCT03310138) | Medical University of South Carolina | 2017-07-06 |
| A Safety, Tolerability, and Efficacy Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness (NCT03163511) | ViaCyte | 2017-07-06 |
| Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations (NCT03185481) | Pfizer | 2017-07-06 |
| Study Assessing the Efficacy and Safety of Intravitreal Injections of DE-122 in Combination With Lucentis® Compared to Lucentis® Monotherapy in Wet Age-related Macular Degeneration Subjects (NCT03211234) | Santen Inc. | 2017-07-05 |
| Effects of Erythropoietin on Cognition and Neural Activity in Mood Disorders (NCT03315897) | Lars Vedel Kessing | 2017-07-05 |
| Neoadjuvant Biomarker ResearcH Study of Palbociclib Combined With Endocrine Therapy in Estrogen Receptor Positive/HER2 Negative Breast CAncer (NeoRHEA) (NCT03065621) | Jules Bordet Institute | 2017-07-05 |
| Renal AL Amyloid Involvement and NEOD001 (NCT03168906) | Tufts Medical Center | 2017-07-05 |
| A Trial to Evaluate Safety, Tolerability and Efficacy of Elamipretide in Subjects With Barth Syndrome (NCT03098797) | Stealth BioTherapeutics Inc. | 2017-07-05 |
| Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery (NCT03113825) | Avelas Biosciences, Inc. | 2017-07-05 |
| Evaluating Combination Immunotherapy for Advanced Cholangiocarcinoma With Pembrolizumab and PEG-Intron (NCT02982720) | Aiwu Ruth He, MD | 2017-07-05 |
| Intravitreal Aflibercept Injection for Radiation Retinopathy Trial (NCT03085784) | Amy C Schefler, MD | 2017-07-05 |
| BUCY+VP-16 vs BUCY Conditioning Regimen for DLBCL Undergoing Auto-HSCT (NCT03229616) | Nanfang Hospital, Southern Medical University | 2017-07-05 |
| Ketamine and Postoperative Depressive Symptom-PASSION (NCT03086148) | Beijing Tiantan Hospital | 2017-07-05 |
| Clinical Trial of the Safety and Efficacy of the Addition of Ramucirumab to Nab-paclitaxel in Previously Treated Patients With Advanced Non-small Cell Lung Cancer (NSCLC) (NCT02730247) | Liza Villaruz, MD | 2017-07-05 |
| A Retrospective Clinical Study of Apatinib in Combination With Radiotherapy / Chemotherapy Second-line and Above in the Treatment of Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma (NCT03424291) | Henan Cancer Hospital | 2017-07-05 |
| An Investigator-initiated Study of Apremilast to Demonstrate Efficacy Nummular Eczema (NCT03160248) | Technical University of Munich | 2017-07-05 |
| Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor (NCT03214354) | University of Calgary | 2017-07-05 |
| Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types (NCT03012620) | UNICANCER | 2017-07-05 |
| A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer) (NCT03193190) | Hoffmann-La Roche | 2017-07-05 |
| Safety and Efficacy of Merlin (Ethanol and Glycolic Acid Mixture) for Episodic Treatment of Cold Sores (NCT03192306) | Topical Remedy | 2017-07-05 |
| Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer (NCT03241914) | Fudan University | 2017-07-04 |
| Study to Evaluate the Efficacy, Safety and Tolerability of PXT002331 (Foliglurax) in Reducing Motor Complications of Levodopa Therapy in Parkinson Disease's Patients (NCT03162874) | Prexton Therapeutics | 2017-07-04 |
| Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer (NCT02905318) | Canadian Cancer Trials Group | 2017-07-04 |
| A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer (NCT03148795) | Pfizer | 2017-07-04 |
| Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia (NCT03241888) | Fudan University | 2017-07-04 |
| Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer (NCT03093870) | ASLAN Pharmaceuticals | 2017-07-04 |
| Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1) (NCT02758587) | NHS Greater Glasgow and Clyde | 2017-07-04 |
| A Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic Cancer (NCT03167112) | Petr Kavan | 2017-07-03 |
| An Open-Labeled Exploratory Study to Evaluate Safety and Efficacy of FB825 in Adults With Atopic Dermatitis (NCT03758716) | Fountain Biopharma Inc. | 2017-07-03 |
| A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis (NCT03230292) | UCB Biopharma SRL | 2017-07-03 |
| A Safety and Efficacy Study of ChAdOx1 LS2 and MVA LS2 (NCT03203421) | University of Oxford | 2017-07-03 |
| A Study of Apatinib Plus Docetaxel for Treatment of Advanced Non-squamous Non-small Cell Lung Cancer With Bone Metastases (NCT03127319) | Affiliated Hospital of Hebei University | 2017-07-03 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of 3 Doses of MOTREM (Nangibotide) in Patients With Septic Shock (NCT03158948) | Inotrem | 2017-07-03 |
| Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma (NCT02911142) | National Cancer Institute (NCI) | 2017-07-03 |
| A Study to Evaluate the Safety and Efficacy of TS-121 as an Adjunctive Treatment for Major Depressive Disorder (NCT03093025) | Taisho Pharmaceutical R&D Inc. | 2017-07-03 |
| Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery (NCT03212365) | University of Utah | 2017-07-03 |
| Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502) (NCT02918292) | Medical College of Wisconsin | 2017-07-03 |
| Study of Quavonlimab (MK-1308) in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-1308-001) (NCT03179436) | Merck Sharp & Dohme LLC | 2017-07-02 |
| The Effects of Oxytocin in Obese Adults (NCT03043053) | Massachusetts General Hospital | 2017-07-01 |
| A 5 Treatment Period Pharmacokinetic Study Evaluating Dose Proportionality and Food Effects of Diazoxide Choline Controlled-Release Tablet (DCCR) (NCT02893618) | Essentialis, Inc. | 2017-07-01 |
| The Effect in Renal Function on Patients With Type 1 Cardiorenal Syndrome Treated With Two Strategies of Furosemide. (NCT04393493) | Hospital Civil de Guadalajara | 2017-07-01 |
| Study of Pembrolizumab With Lanreotide Depot for Gastroenteropancreatic Neuroendocrine Tumors (NCT03043664) | Duke University | 2017-07-01 |
| CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic Leukemia (NCT03275493) | Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | 2017-07-01 |
| Persisting Effects of Psilocybin (NCT02971605) | Johns Hopkins University | 2017-07-01 |
| A Clinical Study of Apatinib in Patients With Local Progressive/Metastatic Refractory Thyroid Cancer (NCT03199677) | Chinese Academy of Medical Sciences | 2017-07-01 |
| Treatment of Chronic Migraine Headaches. (NCT03220113) | Corona Doctors Medical Clinics, Inc. | 2017-07-01 |
| SBRT and Oncolytic Virus Therapy Before Pembrolizumab for Metastatic TNBC and NSCLC (NCT03004183) | The Methodist Hospital Research Institute | 2017-07-01 |
| Topical Use of 20% Beta Caryophyllene Alone And In Combination With 0.025% Capsaicin for Pain Caused by Osteoarthritis Of The Knee (NCT03152578) | Panag Pharma Inc. | 2017-07-01 |
| Magnetic Resonance Imaging (MRI) of Pulp Regeneration (NCT03804450) | Alexandria University | 2017-07-01 |
| Lonquek for Autologous Stem Cell Mobilization (NCT02488382) | Sheba Medical Center | 2017-07-01 |
| Study of Tocilizumab in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transarterial Chemoembolization (TACE) (NCT02997956) | University of Michigan Rogel Cancer Center | 2017-07-01 |
| A Study of Apatinib in Combination With Raltitrexed Treatment in Patients With Advanced Colorectal Cancer (NCT03344614) | Chinese PLA General Hospital | 2017-07-01 |
| Simvastatin to Prevent SCI-Induced Bone Loss (NCT02946424) | Craig Hospital | 2017-07-01 |
| Apatinib in Refractory Colorectal Cancer (NCT03190616) | The First Affiliated Hospital with Nanjing Medical University | 2017-07-01 |
| Perflutren Protein-Type A Microspheres and Contrast-Enhanced Ultrasound in Improving Response to Radioembolization Therapy in Patients With Liver Cancer (NCT03199274) | Thomas Jefferson University | 2017-07-01 |
| 2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy (NCT03004287) | University of Arkansas | 2017-07-01 |
| Apremilast as Anti-pruritic Treatment in Patients With Prurigo Nodularis (NCT03576287) | Tanja Todberg, MD | 2017-07-01 |
| Apatinib in Treating Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) (NCT03213587) | Zhejiang Cancer Hospital | 2017-07-01 |
| Cheese Consumption and Human Microvascular Function (NCT03376555) | Lacy Alexander | 2017-07-01 |
| Melatonin for Prevention of Post Stroke Delirium (NCT04122599) | University Hospital Tuebingen | 2017-07-01 |
| Durvalumab Plus "Booster" RT for Metastatic Adenocarcinoma Pancreas Cancer Post Chemotherapy (GCC 1598) (NCT02885727) | University of Maryland, Baltimore | 2017-07-01 |
| Controlled Crossover Study of AIONX Antimicrobial Surface for the Prevention of Healthcare-associated Infections (NCT03189043) | Aionx, Inc. | 2017-07-01 |
| Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease (NCT02675959) | New York Medical College | 2017-07-01 |
| Anti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive System (NCT03185988) | Shen Lin | 2017-07-01 |